Human astrocytes are larger and more complex than those of infraprimate mammals, suggesting that their role in neural processing has expanded with evolution. To assess the cell-autonomous and speciesselective properties of human glia, we engrafted human glial progenitor cells (GPCs) into neonatal immunodeficient mice. Upon maturation, the recipient brains exhibited large numbers and high proportions of both human glial progenitors and astrocytes. The engrafted human glia were gap-junctioncoupled to host astroglia, yet retained the size and pleomorphism of hominid astroglia, and propagated Ca 2+ signals 3-fold faster than their hosts. Long-term potentiation (LTP) was sharply enhanced in the human glial chimeric mice, as was their learning, as assessed by Barnes maze navigation, object-location memory, and both contextual and tone fear conditioning. Mice allografted with murine GPCs showed no enhancement of either LTP or learning. These findings indicate that human glia differentially enhance both activity-dependent plasticity and learning in mice.
SUMMARY
Human astrocytes are larger and more complex than those of infraprimate mammals, suggesting that their role in neural processing has expanded with evolution. To assess the cell-autonomous and speciesselective properties of human glia, we engrafted human glial progenitor cells (GPCs) into neonatal immunodeficient mice. Upon maturation, the recipient brains exhibited large numbers and high proportions of both human glial progenitors and astrocytes. The engrafted human glia were gap-junctioncoupled to host astroglia, yet retained the size and pleomorphism of hominid astroglia, and propagated Ca 2+ signals 3-fold faster than their hosts. Long-term potentiation (LTP) was sharply enhanced in the human glial chimeric mice, as was their learning, as assessed by Barnes maze navigation, object-location memory, and both contextual and tone fear conditioning. Mice allografted with murine GPCs showed no enhancement of either LTP or learning. These findings indicate that human glia differentially enhance both activity-dependent plasticity and learning in mice.
INTRODUCTION
The unique processing capabilities of the human brain reflect a number of evolutionary adaptations by its cellular constituents (Fields, 2004) . One especially distinct feature of the adult human brain's cellular composition is the size and complexity of its astrocytic cohort. Human astrocytes are both morphologically and functionally distinct from those of infraprimate mammals, in that human astroglia are larger and exhibit far greater architectural complexity and cellular pleomorphism, as well as more rapid syncytial calcium signaling, than their murine counterparts (Colombo, 1996; Oberheim et al., 2009 ). These phylogenetic differences are of particular interest, since astrocytes can both coordinate and modulate neural signal transmission (Rusakov et al., 2011; Verkhratsky et al., 1998) . These observations promise to fundamentally transform our view of astrocytes, since current concepts of the role of astrocytes in neural network performance are based almost entirely on studies of astrocytic physiology in the rodent brain (Oberheim et al., 2006) .
In this study, we have used a human glial chimeric mouse brain to ask whether the structural complexity and unique functional properties of human astrocytes influence activity-dependent plasticity in an otherwise stable neural network. In particular, we have tested the hypothesis that human astrocytes might enhance synaptic plasticity and learning relative to their murine counterparts.
RESULTS

Human Glial Progenitors Exhibit Cell-Autonomous Astrocytic Differentiation in Mouse Brain
To study human astrocytes in the live adult brain, we generated chimeric mice in which human glial progenitor cells (GPCs)-isolated by being sorted on the basis of an A2B5 + /PSA-NCAM À phenotype, and then being expanded via a protocol that promoted differentiation into hGFAP-and A2B5-expressing astrocytes ( Figure S1A available online)-were xenografted into neonatal immune-deficient mice; these matured to become adults chimeric for both mouse and human astroglia (Windrem et al., 2004 (Windrem et al., , 2008 ( Figure 1A ). The human GPCs were labeled ex vivo, prior to implantation, with VSVg-pseudotyped lentiviral-CMV-EGFP; in antecedent pilot experiments, we had determined that this vector sustained the expression of EGFP by astroglia for at least 1 year in vivo ( Figure 1A ). The neonatally implanted mice were sacrificed at time points ranging from 0.5 to 20 months of age, and their brains were assessed both histologically and electrophysiologically. Human donor cells were first identified based on their expression of human nuclear antigen (hNuclei). The hNuclei + cells were found to distribute relatively evenly throughout the forebrain, infiltrating both hippocampus and cortex ( Figure 1B ). Human astrocytes were specifically identified by their intricate EGFP + fluorescent processes and, in fixed tissue, by their coexpression of human glial fibrillary acidic protein (hGFAP) and hNuclei ( Figure 1C ). By 4-5 months of age, mice engrafted with human GPCs exhibited substantial addition of human astrocytes to both the hippocampus and deep neocortical layers; by 12-20 months, human astrocytes further populated large regions of the amygdala, thalamus, neostriatum, and cortex ( Figures 1D-1F ). The human astrocytes appeared to develop and mature in a cell-autonomous fashion, maintaining their larger size and more complex structure relative to murine astrocytes ( Figures 1G and 1H ). Human astrocytes, defined as EGFP + /hGFAP + /hNuclei + , regularly extended processes that terminated in end-feet contiguously arrayed along blood vessel walls (Figures 2A and 2B ). Their long processes were often tortuous and resembled the processes of interlaminar astroglia, a phenotype previously described only in adult human and ape brain (Oberheim et al., 2006 ) ( Figure 2C ); these cells are characterized by long, unbranched processes that traverse multiple cortical laminae (Colombo, 2001 ). Many of the engrafted human astrocytes in chimeric mice extended processes that spanned >0.5 mm ( Figure 2D) . A large number of mitochondria were present in the long processes ( Figure 2E ). Other engrafted human cells exhibited the long, varicosity-studded processes of varicose projection astrocytes, a second class of hominid astrocytes (Oberheim et al., 2009) . Of note, rag2 À/À immunodeficient mice on a C3h background were generally used as recipients for these experiments, although rag1 À/À immunodeficient mice (on a C57/Bl6 background) were used for vision-dependent behavioral tests, since the C3h background of the rag2 mice is a visually impaired strain; we observed no difference in xenograft acceptance, cell dispersal, or differentiation patterns between these two hosts. (D) At 5 months, EGFP + cells typically infiltrated corpus callosum and cortical layers V and VI. All EGFP + cells labeled with an antibody directed against human nuclear antigen (hNuclei) and most of the human cells were also labeled with an antibody directed against human GFAP (hGFAP, red). (E) At 11 months, many areas of cortex were infiltrated by evenly distributed EGFP + /hNuclei + cells.
(F) The hippocampus was also populated with EGFP + /hNuclei + cells in a 14-month-old animal, with the highest density in the dentate.
(G) Human EGFP + /hNuclei + /GFAP + cells (green arrows) were significantly larger than host murine astrocytes (red arrow). The anti-GFAP antibody cross-reacted with both human and mouse GFAP (red). Inset shows same field in lower magnification. (H) Histogram comparing the diameter of mouse cortical astrocytes to human cortical astrocytes in situ (freshly resected surgical samples) and xenografted human astrocytes in cortex of chimeric mouse brain. The maximal diameter of mouse and human astrocytes (in situ and in chimeric mice) was determined in sections stained with an anti-GFAP antibody that labels both human and mouse GFAP. (n = 50-65; **p < 0.01, Bonferroni t test.) EGFP, green; hNuclei, white and white arrow; DAPI, blue (B-F). Scale bars: 50 mm (C); 100 mm (D-F); and 10 mm (G). Data graphed as means ± SEM. See also Figure S1 .
In that regard, we found no evidence of microglial activation in the xenografted mice, whether in rag1 null or rag2 null hosts, reflecting both their neonatal engraftment and immunodeficient backgrounds (Figures S1B-S1F). Figure 2F) . A large number of hNuclei + cells failed to express GFAP but did express a human-specific isoform of the chondroitin sulfate proteoglycan NG2 ( Figure 2G ), a prototypic marker of parenchymal glial progenitor cells (Mangin and Gallo, 2011; Robel et al., 2011 mice ( Figure 2G ). Transferrin immunostaining failed to detect any human oligodendroglia, consistent with our prior assessment of glial progenitor cell fate upon transplantation to normally myelinated brain (Windrem et al., 2009) (Figures S2A and S2B) : whereas a large proportion of engrafted human GPCs differentiate into oligodendrocytes in hypomyelinated shiverer mice, essentially no human oligodendrocytes were found in similarly engrafted wild-type mice (Windrem et al., 2009 ).
Human GPCs and Astrocytes Exhibited Distinct Physiological Phenotypes in Mouse Brain
To evaluate the electrophysiological properties of human astrocytes engrafted in mice, acute hippocampal slices were prepared from chimeric mice ranging from 4 to 10 months of age (6.5 ± 0.4 months old, mean ± SD). Donor astrocytes could be readily identified by their EGFP fluorescence and by their large, symmetric, highly branched astrocytic morphologies.
The tagged donor cells were filled with Alexa 594 or the Ca 2+ indicator rhod2 during whole-cell recordings, and their phenotype was verified by immunolabeling for GFAP ( Figure 3A ). EGFP + human astrocytes exhibited a higher input resistance than that of host murine astrocytes (51.6 ± 2.5 MU, n = 37, versus 29.2 ± 3.2 MU, n = 17, respectively, means ± SEM; p < 0.05, Steel-Dwass test). In contrast, the resting membrane potential of human astrocytes (À69.2 ± 1.5 mV, n = 37) was not significantly different from that of untagged host astrocytes (À73.9 ± 1.7 mV, n = 17, p > 0.05) ( Figures 3B-3D ). Whereas all large and symmetric EGFP + donor cells exhibited passive membrane currents and linear current to voltage (I/V) curves, another population of smaller EGFP + human cells with compact, asymmetrically branched morphologies manifested a much higher input resistance (147.8 ± 11.7 MU, n = 14). These donor cells manifested voltage-gated currents and depolarization-triggered outward currents with delayed activation ( Figure 3B ) and expressed a human epitope of chondroitin sulfate proteoglycan NG2, identifying them as persistent glial progenitors ( Figure 2G ) (Kang et al., 2010; Robel et al., 2011) . Together, these histological and electrophysiological analyses supported the notion that a large proportion of engrafted human cells differentiated into protoplasmic astrocytes, forming a functional syncytium with their murine host, and that these were accompanied by large numbers of coengrafted NG2 + human glial progenitors.
Human Astrocytes Propagate Calcium Waves More Quickly than Do Murine Astroglia
Astrocytes are electrically nonexcitable and are incapable of electrochemical communication. Instead, the principle mechanism of astrocytic signaling involves transient elevations of cytosolic Ca 2+ (Cotrina and Nedergaard, 2005 (Parpura and Verkhratsky, 2012; Rusakov et al., 2011) . Photolysis of caged Ca 2 loaded specifically into astrocytes was used to avoid potentially confounding alterations in local synaptic activity. Intracellular Ca 2+ waves were evoked when we directed a UV beam at long processes of astrocytes filled with rhod2 and NP-EGTA by a patch pipette. The subsequent spread of Ca 2+ signals was visualized using two-photon excitation ( Figure 3E ). Line scanning with high temporal resolution (2-4 ms) showed that intracellular Ca 2+ wave propagation was significantly faster in human astrocytes than in murine cells; intracellular Ca 2+ increases propagated with a velocity of 15.8 ± 0.7 mm/s among human glia compared to 5.7 ± 0.4 mm/s in resident murine astrocytes (n = 22-34, 6.5 ± 0.4 versus 7.0 ± 0.5 months old, mean ± SEM, p < 0.05, Steel-Dwass test) ( Figures 3F-3H ). To determine whether the faster intracellular Ca 2+ waves in human astrocytes
were an artifact of xenograft, we also assessed intracellular Ca 2+ wave spread in slices of fresh human brain tissue obtained at surgical resection for distant lesions (mean age of patients: 30.6 ± 8.8 years, n = 3). Human astrocytes in these surgical resections similarly propagated intracellular Ca 2+ waves much more rapidly than did murine astrocytes (n = 10) ( Figure 3H ). Together, these experiments demonstrated that intracellular Ca 2+ signals propagate at least 3-fold faster within human astrocytes than in their rodent counterparts, and do so in human glial chimeric mice just as in human brain tissue. Of note, we were unable to evaluate intercellular Ca 2+ wave propagation, as only slices prepared from young mice pups load well with esterified (AM) Ca 2+ indicators (Dawitz et al., 2011) .
Human Astrocytes Accentuate Excitatory Synaptic Transmission in the Murine Hippocampus
A principal function of astrocytes is to monitor local synaptic activity by their expression of metabotropic neurotransmitter receptors for both glutamate and GABA (Parpura and Verkhratsky, 2012; Rusakov et al., 2011) . These receptors activate intracellular signaling pathways, mediated primarily by increases in cytosolic Ca
2+
, which are linked to synaptic plasticity (Parpura and Zorec, 2010) . To assess the selective impact of human astrocytes on neural transmission within the host murine neural network, we compared synaptic activity in hippocampal slices prepared from human glial chimeric mice to that of both their unengrafted and allografted littermate controls. We focused on the hippocampal dentate granule layer because of the many electrophysiological and behavioral tests by which hippocampal function, learning, and LTP could be assessed (Lee and Silva, 2009 ). In addition, human cells typically densely engrafted this area; these included an admixture of GFAP + / hNuclei + and NG2 + /hNuclei + cells ( Figures 1B, 1F , and 2G). Stimulation of the medial perforant path (Colino and Malenka, 1993) consistently evoked a significantly steeper slope of field excitatory postsynaptic potentials (fEPSP) in the humanized chimeric mice than that in either their uninjected littermates or mouse GPC allografted controls (n = 3-40, F = 3.15, by two-way ANOVA, p = 0.044) ( Figure 4A ). The allograft controls comprised a set of mice neonatally engrafted with murine GPCs derived from EGFP transgenic mice, and they otherwise underwent the same isolation and engraftment protocols as those using human GPCs. The steeper slope of the fEPSPs in the humanized chimeras compared to that of the uninjected controls was still evident after normalization to the fiber volley amplitudes, a measure thought to reflect the number of stimulated axons ( Figure S3A ). Thus, slices with human glia exhibited a significant enhancement in their basal level of excitatory synaptic transmission over a wide range of stimulation intensities.
Human Astrocytes Enhance LTP in the Adult Murine Hippocampus
We next asked if human astrocytes might affect synaptic plasticity by assessing the effect of human glia on long-term potentiation (LTP). Two trains of high-frequency stimulation (HFS) potentiated the fEPSP slope to 151.2% ± 8.1% of baseline in chimeric mice, compared with 138.6% ± 7.6% in control littermates (n = 7 mice in both groups, 13.8 ± 1.1 versus 12.6 ± 0.4 months old, respectively, ages provided as mean ± SEM) ( Figure 4B ). The enhancement of fEPSP slope persisted at 60 min in humanized chimeric mice (113.6% ± 3.8%, p < 0.05), whereas fEPSP slope in unengrafted controls fell to 103.2% ± 3.9% (not significantly different from the fEPSP slope prior to HFS, p = 0.169). Mouse allografted controls exhibited an initial increase to 138.5% ± 2.3%, which fell to 103.8% ± 1.3% at 60 min (not significantly different from the fEPSP slope prior to HFS, n = 7, 14.0 ± 0.1 months old, p = 0.29, t test) ( Figure 4B ). Thus, the observed enhancement of LTP was a specific feature of human glial chimerization, and was not attributable to cell engraftment per se.
The enhancement of LTP can result from both presynaptic and postsynaptic mechanisms. An analysis of paired-pulse facilitation before and after HFS in chimeric mice suggested that postsynaptic mechanisms most likely underlie the enhancement of fEPSP slope in humanized chimeric mice ( Figures S3B and S3C) . To evaluate the relative contribution of AMPA-and NMDA-receptor-mediated currents to the enhancement in LTP in the chimeric mice, we analyzed the effect of NMDA receptor blockade using the NMDA receptor antagonist APV. We found that the NMDA receptor component accounted for only 4.7%-12% of fEPSP, with no significant differences across the groups analyzed, indicating that NMDA NR1 expression was not increased in the human glial chimeras. These findings suggest that NMDA receptor activation played a minor role, if any, in the enhancement of synaptic plasticity in the chimeric mice (n = 15-27) ( Figure 4C ). Since NMDA receptors have a higher affinity for glutamate than do AMPA receptors (Malinow and Malenka, 2002) , these observations also suggest that the potentiation of fEPSPs in human glial chimeric mice was not the result of increased synaptic release of glutamate; this is consistent with the lack of enhancement of paired-pulse suppression in the chimeric mice ( Figures S3B  and S3C ).
Neither Adenosine nor D-Serine Accounted for the Enhancement of LTP by Human Glia Several mechanisms exist by which astrocytes can modulate excitatory transmission. Astrocytes release ATP, which, after degradation to adenosine by extracellular ectonucleotidases, can suppress both basal synaptic transmission and activitydependent increases in synaptic strength (Pascual et al., 2005; Zhang et al., 2003) . However, it seems unlikely that adenosine contributed to the enhanced synaptic strength observed in the xenografted mice. The A1 receptor antagonist 8-cyclopentyl-1,3-dipropylxanthine (DPCPX) (Grover and Teyler, 1993; Wu and Saggau, 1994) did not decrease the threshold for induction of LTP in control mice; in slices exposed to 100 nM DPCPX, the fEPSP slope returned to 101.9% ± 3.6% 60 min after HFS, similar to untreated slices ( Figures 4D and 4E) . Thus, it is unlikely that the reduced threshold for LTP in chimeric mice was a consequence of altered adenosine concentrations.
Astrocytes can also modulate excitatory transmission via their release of D-serine (Panatier et al., 2006; Yang et al., 2003) . D-serine acts as an endogenous coagonist of NMDA receptors and facilitates NMDA receptor activation, thereby potentiating the insertion of additional AMPA receptors into the postsynaptic membrane (Panatier et al., 2006; Yang et al., 2003) . We tested the effect of adding D-serine to the bath of slices prepared from control mice. D-serine had no effects on the fEPSP slopes in accordance with previous reports (p = 0.216, n = 6) (Panatier et al., 2006; Yang et al., 2003) . Moreover, neither D-serine nor immunolabeling for its synthetic enzyme, serine racemase, differed between human glial chimeric and uninjected control mice ( Figures S3D and S3E ). These observations suggest that the lower threshold for induction of LTP in human glial chimerics 
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Human Glial TNFa Potentiates Synaptic Transmission via an Increase in GluR1 Receptors
Release of the cytokine TNFa comprises an alternative mechanism by which glia might modulate LTP. Cultured astrocytes constitutively release TNFa, which induces the addition of AMPA receptors to neuronal membranes, thereby enhancing excitatory synaptic transmission (Beattie et al., 2002; Stellwagen and Malenka, 2006) . To assess the involvement of TNFa in the strengthening of excitatory transmission in the human glial chimeric mice, we first confirmed that TNFa increased both AMPA receptor current ( Figure 5A ) and AMPA GluR1 immunolabeling in hippocampal slices ( Figure 5B ). In contrast, TNFa did not affect expression of the NMDA receptor NR1 subunit in the same slices ( Figure 5B) . On that basis, we next asked whether chimeric mice expressed human TNFa. Using qPCR (B) Hippocampal slices exposed to TNFa (600 nM; 2-4 hr) exhibited an increase in the intensity of the GluR1 subunit of AMPA receptors as seen via immunolabeling, but not in that of the NR1 subunit of NMDA receptors (n = 5, 9-11 months, **p < 0.01, t test). (C) Human chimeric mice exhibited a higher intensity of immunolabeling for TNFa and GluR1, but not for NR1 (n = 7, 7-20 months, *p < 0.05, **p < 0.01, t test). (hNuclei, white; representative human cells, white arrows). (D) Thalidomide also decreased the immunolabeling of TNFa and GluR1, but not that of NR1, in chimeric mice (hNuclei, white; n = 6, 12-16 months, *p < 0.05, **p < 0.01, t test). (E) The facilitation of LTP in chimeric mice was impaired by thalidomide (n = 6, 12.6 ± 0.3 versus 12.5 ± 0.5 months old, respectively, means ± SEM, p < 0.05, t test). (F) Thalidomide did not change the contribution of NMDA receptor activation to fEPSP. Recordings of fEPSPs were obtained before and after addition of the NMDA receptor antagonist APV (50 mM), and the difference was calculated (n = 4). (G) Phosphorylation of the Ser831 site of GluR1 was increased in chimeric mice compared with unengrafted littermate controls. Thalidomide attenuated the increase in phosphorylation of the Ser831 site of GluR1, but had no effect in unengrafted littermate controls, white arrows shows hNuclei + cells. (n = 6, 9-16 months, *p < 0.05, t test). Scale bars: 100 mm (B, C, D, and G). All data are graphed as means ± SEM. See also Figure S4 .
we found that human-specific sequence encoding TNFa was indeed highly expressed in the chimeras, yet undetectable in unengrafted mice ( Figure S4A ). Immunolabeling confirmed that the human glial chimeras exhibited significant increases in both TNFa and GluR1, but not in NR1 ( Figure 5C ). We thus asked whether the inhibition of TNFa production might suppress excitatory hippocampal transmission in chimeric mice, and if so, whether TNFa inhibition might abrogate the effects of human glial chimerization on LTP. Previous studies have analyzed the effect of TNFa on excitatory transmission in vitro by adding soluble TNFR1 receptors to scavenge free TNFa (Beattie et al., 2002; Stellwagen and Malenka, 2006) . Since soluble TNFR1 would not be expected to be an efficient inhibitor in vivo, we instead administered thalidomide, a potent, BBB permeable inhibitor of TNFa production (Ryu and McLarnon, 2008) . Human glial chimeric mice treated with thalidomide exhibited a significant suppression of fEPSP slopes compared to those receiving vehicle (0.5% carboxymethylcellulose) (1.41 ± 0.15 mV/ms versus 1.05 ± 0.24 mV/ms at 0.1 mA, means ± SEM, p < 0.05, n = 12). In contrast, excitatory transmission in unengrafted littermates was unaffected by thalidomide (1.02 ± 0.12 mV/ms versus 0.97 ± 0.20 mV/ms at 0.1 mA, p = 0.32, n = 12). These observations suggested that thalidomide selectively targeted the potentiation of excitatory transmission mediated by human glial TNFa. Accordingly, thalidomide also reduced the expression of both TNFa and GluR1 in the human glial chimeras, but not that of NR1 ( Figure 5D ). Importantly, thalidomide also prevented the facilitation of LTP in the human glial chimeras: two trains of HFS failed to trigger LTP in slices taken from chimeras pretreated with thalidomide (106.3% ± 3.9%, n = 6, 12.6 ± 0.3 months of age), whereas the activity-dependent potentiation of fEPSPs persisted in vehicletreated human glial chimeras (117.6% ± 4.8%, n = 6, 12.5 ± 0.5 months, p < 0.05, t test) ( Figure 5E ). Thalidomide did not alter the number of NMDA receptors activated in response to medial perforant-path fiber stimulation in either chimeric or unengrafted controls, suggesting that thalidomide specifically suppressed the number of functional AMPA receptors consistent with prior publications showing that TNFa drives membrane insertion of AMPA receptors ( Figure 5F ) (Beattie et al., 2002; Stellwagen and Malenka, 2006) . Thus, TNFa released by human glial cells ( Figure S4A , Figure 5C ) enhanced host neuronal fEPSPs by increasing the number of functional postsynaptic GluR1 AMPA receptors ( Figure 5C ), and conversely, thalidomide suppressed plasma membrane insertion of AMPA receptors, but not NMDA receptors, by inhibiting TNFa production ( Figure 5D ).
TNFa regulates a number of cellular processes through protein kinase C (PKC)-mediated phosphorylation (Faurschou and Gniadecki, 2008) , which is thus disrupted by thalidomide. Since phosphorylation of GluR1, at sites critical for its synaptic delivery, is both necessary and sufficient for lowering the threshold for inducing LTP (Hu et al., 2007) , we thus next asked if the phosphorylation state of the GluR1 subunit differed between human glial chimeric mice and their littermate controls. We focused on two phosphorylation sites, Ser845 (PKA site) and Ser831 (PKC/CaMKII site), each of which is critical for the synaptic insertion of GluR1 (Hu et al., 2007) , and assessed the effects upon each of human glial chimerization and of thalidomide. Quantitative immunohistochemistry revealed that human glial chimeric mice exhibited a significant increase in Ser831 phosphorylation, the PKC-sensitive site (n = 6, p = 0.008, t test); this was significantly attenuated in human glial chimeras receiving thalidomide, but not in their unengrafted control littermates (n = 9-10; p > 0.4, t test) ( Figure 5G ). In contrast, phosphorylation of the Ser845 PKA site was unaffected either by the engraftment of human glia or by thalidomide (n = 6, p > 0.05, t test) (Figures S4B and S4C) . Together, these results suggested that human glia facilitate synaptic insertion of the GluR1 subunit in host murine neurons through a TNFa-dependent, PKC/CaMKII-mediated pathway, which lowers the threshold for induction of LTP in human glial chimeric mice.
Enhanced Learning in Humanized Chimeric Mice
Stable, long-lasting changes in synaptic function, such as those revealed by our LTP studies, are thought to be involved in learning and memory (Lee and Silva, 2009 ). Since LTP was markedly enhanced in human glial chimeric mice, we next asked if these mice also exhibited improved learning. We first assessed whether auditory fear conditioning (AFC)-a task in which the mice learn to fear an innocuous tone by pairing it with foot shock (Zhou et al., 2009) , and which does not require visual input (rag2 À/À mice are blind)-was potentiated in the human glial chimeras. To this end, we compared the rate of acquisition of AFC in xenografted human glial chimeras to that of both allografted murine glial chimeras and unengrafted littermate controls ( Figure 6A ). The allografted mice-which were also generated in immunodeficient rag2 null hosts-received neonatal grafts of A2B5 + cells isolated from transgenic mice with constitutive EGFP expression, which allowed us to readily identify murine donor cells. After just a single pairing of the tone with foot shock, the human glial chimeric mice exhibited a significant enhancement in learning of the tone foot shock association: they showed greater fear to the tone as measured by scoring freezing behavior (the cessation of all movement except for respiration) than did either allografted chimeras or unengrafted controls (n = 5-20, 9.6 ± 1.0 months old, F = 18.9, two-way repeated-measures ANOVA, p < 0.001). Moreover, after 3 continuous days of training, humanized chimeric mice also showed enhanced AFC during the 3 remaining days of testing, as manifested by their higher levels of freezing in response to the conditioned tone (p < 0.01, post hoc Bonferroni test). In contrast, neither murine glial chimeric mice nor unengrafted controls manifested any increase in freezing behavior during the same period, despite having been subjected to an identical fear conditioning paradigm (p > 0.05; Bonferroni test) ( Figure 6A ). Of note, no differences were observed between the human glial chimeras and their controls in the reaction to foot shock (n = 5, 9.6 ± 1.0 months old, F = 0.08 by two-way ANOVA, p > 0.5) ( Figure S5A ), suggesting that their respective nociceptive thresholds were analogous. To specifically assess hippocampus-dependent learning, we next prepared chimeric mice using rag1 immunodeficient mice (maintained on a C57/Bl6 background), which differ from their rag2 null counterparts (on a C3h background) by having normal vision. We first compared the net engraftment of human GPCs, as well as their relative differentiation into hNG2 + GPCs or GFAP + astroglia, in human glial chimeras established in rag1 null and rag2 null mice. We focused on hippocampal learning, as this region was used for our analysis of LTP (Lee and Silva, 2009; Manns and Eichenbaum, 2009 ). We found that both the engraftment and differentiation of human GPCs in rag1 and rag2 immunodeficient mice were indistinguishable from one another ( Figures S5B and S5C) . On that basis, we next assessed the effect of chimerization of rag1 null immunodeficient mice on contextual fear conditioning (CFC), a hippocampal-dependent task in which mice learn to fear a context in which they receive a foot shock (Fanselow and Poulos, 2005) . The human glialchimeric mice exhibited enhanced performance in CFC throughout all 4 days of training ( Figure 6B ). By just the second day, the human glial chimeric mice exhibited substantially more rapid and robust CFC than their nonchimeric littermate controls (n = 6, 6.9 ± 0.1 months of age, F = 14.8 by two-way repeated-measures ANOVA, p = 0.003), and continued to display enhanced CFC during the subsequent 2 days of CFC training ( Figure 6B ). To exclude the possibility that a generalized increase in freezing behavior could explain the observed differences, we also examined the context specificity of freezing responses. In these experiments, the mice were placed in a second chamber with a different floor and odor. Chimeric mice exhibited superior discrimination between the two contexts, suggesting stronger contextual learning, as opposed to a nonspecific higher level of fear (n = 8-13, 7.6 ± 0.1 months, p < 0.05, t test) ( Figure 6B ). No differences were observed in the reaction times to foot shock between the human glial chimeras and their rag1 null immunodeficient controls (n = 5, 9.6 ± 0.95 months, F = 0.08 by two-way ANOVA, p > 0.5) ( Figure S5A ). Moreover, neither thermal nor mechanical sensitivity were affected by chimerization of either rag1 or rag2 mice ( Figures S5D and S5E ), suggesting that their respective nociceptive thresholds were analogous. To better assess the scope of performance enhancement in the human glial chimeras, we next assessed their performance in the Barnes maze, another hippocampal-dependent learning task. In this spatial learning task mice learn the location of a hole that leads to an escape/drop box. By just the second day of serial daily testing, the human glial chimeras made fewer errors and displayed a significantly shorter latency in finding the drop box compared to their littermate controls (n = 6, 7.4 ± 0.1 months, F = 13.4 by two-way repeated-measures ANOVA, p = 0.004) ( Figure 6C ). These differences persisted throughout the four-trial testing period (n = 6, 7.4 ± 0.1 months, F = 11.4, p = 0.007). With additional training, the unengrafted control mice were capable of completing the task, indicating (A) Auditory fear conditioning assessed in a cohort of human chimeric, mouse chimeric, and unengrafted control rag2 null mice. Chimeric mice exhibit prolonged freezing behavior in test chamber 2 during exposure to the tonal conditioned stimulus when compared to unengrafted mice and allografted mice (n = 5-20, *p < 0.05, **p < 0.01, two-way repeated-measures ANOVA with Bonferroni test, means ± SEM). This difference persisted throughout all 4 days. (B) Contextual fear conditioning in human glial chimeric mice and littermate control rag1 null mice. Freezing behavior was quantified for chimeric and unengrafted littermate controls during the 2 min acclimatization period (n = 6, *p < 0.05, **p < 0.01, two-way repeated-measures ANOVA with Bonferroni test). In addition the mean discrimination ratio for each day was obtained from freezing scores in the training chamber and the alternative chamber (freezing in training chamber/total freezing time). Chimeric mice demonstrated significantly greater abilities to discriminate the chambers (n = 8-13, *p < 0.05, **p < 0.01, two-way repeated-measures ANOVA with Bonferroni test). (C) Barnes maze testing in chimeric and unengrafted rag1 null littermate controls. Chimeric mice demonstrated a significant learning advantage, as reflected in a shorter latency and fewer errors in solving the maze (n = 6, *p < 0.05, **p < 0.01, two-way repeated-measures ANOVA with Bonferroni test). (D) Object-Location Memory Task (OLT) in chimeric mice and their unengrafted rag1 null littermate controls demonstrated a learning advantage in chimeric mice via enhanced recognition of the novel displaced object. Thalidomide eliminated the learning advantage of chimeric mice, suggesting that the learning enhancement was TNFa mediated (n = 7, **p < 0.01, one-way ANOVA with Bonferroni test). All data are plotted as means ± SEM. See also Figure S5 . that they could master the task if given sufficient training ( Figure S5F ).
Next, we tested the mice in the Object-Location Memory Task (OLT), another hippocampal-dependent task (Manns and Eichenbaum, 2009) . OLT tests the ability of the animal to recognize a familiar object in a novel location. Chimeric mice exhibited a substantially greater preference for objects in novel locations than their controls (58.6% ± 4.8% versus 41.8% ± 2.3%, means ± SEM, n = 7, 7.2 ± 0.1 months, p = 0.008, t test) ( Figure 6D ). Thalidomide treatment did not affect appreciably the performance of the unengrafted littermate controls on the OLT, but reduced the performance of the human glial chimeric mice to the levels of controls (n = 7, 7.8 ± 0.1 months, p = 0.82, t test) ( Figure 6D ). Thus, thalidomide selectively abrogated the chimerization-associated performance enhancement of the human glial chimeras.
Together, these results indicate that relative to either unengrafted mice or mice allografted with A2B5 + -sorted, EGFP + murine GPCs, human glial chimeric mice exhibit enhanced performance in four different learning tasks: AFC, CFC, Barnes maze, and novel object location. Moreover, the analysis of AFC indicates that alloengraftment by mouse GPCs did not affect the learning of the recipient mice, supporting the notion that the improved learning in the humanized chimeras resulted from the presence of human glia, rather than from cell engraftment per se. As an additional control, we also noted that social interactions did not differ between human chimeras generated by engraftment in rag1 mice and their littermate controls (n = 5, 6.9 ± 0.1 months, p > 0.05, t test) ( Figures S5G and S5H ), indicating that chimerization did not seen to affect their interactions with other mice.
DISCUSSION
Prior studies have documented that astrocytes regulate synaptic transmission and actively participate in the synaptic efficiency of neural circuits in the rodent CNS (Fields, 2004; Nedergaard and Verkhratsky, 2012; Parpura and Verkhratsky, 2012; Rusakov et al., 2011) . A parallel, hitherto nonoverlapping line of work has shown that human astrocytes are larger and far more structurally complex than those of rodents (Colombo, 1996; Oberheim et al., 2009) ; this has led to the hypothesis that astrocytic evolution has been critical to the increased scope and capacity of central neural processing that have attended hominid evolution (Colombo, 1996; Oberheim et al., 2006 Oberheim et al., , 2012 . In support of this hypothesis, genomic studies have revealed that the greatest differences in brain gene expression between humans and mice are in glial transcripts (Miller et al., 2010) . In this study, we created human glial chimeric mice, in which immunodeficient but otherwise normal mice were engrafted neonatally with large numbers of human glial progenitors, resulting in the widespread integration of human glia into the mouse brain. By the time these mice reached adulthood, a large proportion of their forebrain glia were replaced by human cells. The chimerization was slowly progressive, so that extensive infiltration of cortex and hippocampus by human cells was evident by 4-12 months (Figure 1) . The xenografted human cells remained as NG2-defined glial progenitor cells or differentiated as hGFAP + astrocytes; remarkably, the latter maintained their characteristic, large, and complex hominid-selective morphologies (Figure 2 ). In addition, some assumed the characteristic long-distance fiber extensions of interlaminar astrocytes, a domain-traversing astrocytic phenotype specific to the hominid brain (Colombo, 2001; Colombo et al., 1995; Oberheim et al., 2006) . Electrophysiological analysis validated that most EGFP + /hGFAP + /hNuclei + human glia were protoplasmic astrocytes, based on their low input resistance, passive membrane properties, extensive gap junction coupling, and Ca 2+ wave propagation (Figure 3) .
The striking population of the recipient mouse brains by human glia raised the possibility that the engrafted human cells might significantly modulate information processing within the host murine neural networks. Indeed, the basal level of excitatory synaptic transmission was increased over a wide range of stimulation intensities. The presence of human glia also enhanced LTP in human glial chimeric hippocampal slices relative to mice that had received conspecific murine glial progenitors or vehicle injection (Figure 4 ). Our analysis showed that TNFa was significantly elevated in the human glial chimeric brains, consistent with the potentiation of AMPA-receptor-mediated currents (Beattie et al., 2002; Stellwagen and Malenka, 2006) . Additional analysis suggested that TNFa may have directly facilitated insertion of the GluR1 subunit into the plasma membrane (Hu et al., 2007) , perhaps via its increased phosphorylation at Ser831. TNFa might also potentiate astrocytic glutamate release (Ni and Parpura, 2009; Parpura and Zorec, 2010) , which in turn could increase GluR1 subunit phosphorylation by NMDAreceptor-mediated activation of PKC ( Figure 5 ) (Malinow and Malenka, 2002) . Both of these pathways might have contributed to the enhancement of hippocampal LTP that we observed in the human glial chimeras, although we found no evidence of enhancement of NMDA receptor activation after engraftment ( Figure 4C ). Importantly, we found that thalidomide, a BBBpermeable inhibitor of TNFa, both diminished the enhancement of postsynaptic AMPA receptor current and reduced LTP in chimeric mice, yet had no such effects in unengrafted littermate controls. Behavioral analyses then revealed that human glial chimeric mice exhibited improved learning and memory in four different tasks, including AFC, CFC, the Barnes Maze, and OLT ( Figure 6 ). As with the chimerization-associated enhancement in LTP, the enhanced learning of chimeric mice in the object location recognition assay was eliminated by thalidomide treatment ( Figure 6D ). Engraftment by neonatally delivered mouse GPCs did not enhance LTP, AFC, or Barnes maze performance, strongly suggesting that the potentiation of synaptic plasticity and learning afforded by glial progenitor cell chimerization was specific to human glia, and not a product of cell engraftment per se ( Figures 4B and 6A) .
Together, these studies demonstrate that human astrocytes generated within the mouse brain maintain their complex phenotype in a cell-autonomous fashion; they assume morphologies and Ca 2+ wave characteristics typical of the human brain, but, to our knowledge, hitherto never observed in experimental animals. These observations strongly support the notion that the evolution of human neural processing, and hence the species-specific aspects of human cognition, in part may reflect the course of astrocytic evolution (Oberheim et al., 2006) . As such, these human glial chimeric mice may present a useful experimental model by which human glial cells, and both normative and pathological species-specific aspects of human glial biology, may now be effectively studied in the live adult brain.
EXPERIMENTAL PROCEDURES
Isolation of Human and Murine Glial Progenitor Cells Fetal glial cell progenitors were extracted from 17-to 22-week-old human fetuses obtained at abortion. The forebrain ventricular and subventricular zones were dissected free on ice and then were dissociated using papain/ DNAase as described (Windrem et al., 2004) . All samples were obtained with consent under approved protocols of the University of Rochester Research Subjects Review Board. Human glial progenitor cells were isolated by magnetic activated cell sorting, as described in the Supplemental Experimental Procedures. In addition, murine A2B5 + cells were identically prepared from newborn Tg(CAG-EGFP)B5Nagy/J pups (Jackson Laboratory).
Transfection and Differentiation
Human A2B5 + /PSA-NCAM À cells were transfected to express enhanced EGFP, and were maintained as described in the Supplemental Experimental Procedures.
Transplantation
Human glial chimeras were prepared as described, using either rag1 À/À or rag2 À/À immunodeficient mice (as described in Windrem et al., 2008 , though using mice wild-type for myelin); see Supplemental Experimental Procedures for additional detail. All experiments were approved by the University of Rochester's Research Animal Care and Use Committee.
Quantitative Immunohistochemistry
Chimeric mice and littermate controls (ranging from 2 weeks to 20 months, depending upon experimental endpoint) were perfusion-fixed, processed histologically, and analyzed as described in the Supplemental Experimental Procedures.
Electrophysiological Characterization of Human Glia in Chimeric Mice
Patch-clamp assessment of engrafted human glia was performed in slice preparations under two-photon microscopy, as detailed in the Supplemental Experimental Procedures.
LTP
Slice preparations of both chimeric mice and their littermate controls (with an age range of 7-20 months) were used for recordings of fEPSPs and analysis of activity-dependent changes in hippocampal synaptic strength, as outlined in the Supplemental Experimental Procedures.
Ca 2+ Imaging and Photolysis of Caged Ca
2+
Chimeric mice (with an age range of 4-10 months) were used for imaging intracellular Ca 2+ in xenografted human glia. In addition, as positive controls, surgical resections of human cortex (n = 3 patients, 30.6 ± 8.8 years old) were obtained with patient consent and the approval of the University of Rochester Research Subjects Review Board; all samples were prepared for physiological assessment and analyzed as described in the Supplemental Experimental Procedures.
Detection of Human TNFa in Human Glial Chimeras RNA isolation, PCR primer design, reverse transcription, and PCR reaction conditions and analysis were all as described in the Supplemental Experimental Procedures.
Learning Tasks and Behavioral Assessment AFC, CFC, Barnes maze navigation, object location memory, Crawley's social interaction tasks, and both thermal and mechanical sensitivity thresholds were assessed in human glial chimeric and control mice; the latter included allografted and/or unengrafted negative controls. All tests and analyses were performed as outlined in the Supplemental Experimental Procedures. 
